University of Nottingham spin-out NuVision received £379k seed funding from Mercia Fund Management
The funding from Mercia will support the commercialisation of NuVision’s ground-breaking product, Omnigen™, an easy to use, dry, amniotic membrane-derived biological bandage that can be used to treat ocular wounds caused by scratches, blisters and burns, as soon as they occur, as well as more long-term, non-healing persistent defects. Omnigen is produced using a pioneering […]